Thursday - October 1, 2026
FDA Center for Drug Evaluation & Research Issues Warning Letter to Kellin Chemicals - Zhangjiagang
October 01, 2026
WASHINGTON, Oct. 1 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Kellin Chemicals Co., Ltd. - Zhangjiagang from its Center for Drug Evaluation and Research:

* * *

Recipient: Zhiyu Du, Marketing and Sales Center Representative, Kellin Chemicals Co., Ltd. - Zhangjiagang, No. 5 Changjiang North Road, Yangzijiang Chemical Industrial Park, Zhenjiang Shi Jiangsu Sheng, 215634, China

Issuing . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products